Microsulis leads the way in Lung and Liver Ablation

May 24, 2010 - PRLog -- Denmead, Hampshire UK.  Acculis Limited today announced the first clinical Computed Tomography body scanner (CT) guided liver and lung ablations using its newly CE Marked high power 2.45GHz microwave system for soft tissue coagulation.  The treatments during April and May 2010 were conducted by Dr Graham Plant, Consultant Interventional Radiologist at The Basingstoke and North Hampshire Hospital, UK.  The system demonstrated its powerful ablation capability as well as compatibility with the CT environment.

“The cases went smoothly and we were able to visualize and percutaneously place the device satisfactorily.  While using conservative power levels in these initial uses, the system rapidly generated the desired coagulation zones as shown on peri and post operative scans.  Longer term follow-up will confirm whether local tumour control has been achieved as expected.” said Dr Plant.

The new Acculis internally cooled percutaneous needle system was CE Marked in February 2010 and is now in distribution in the UK, Europe, South Africa, Australasia and Hong Kong.  Clearances in other countries are in progress.

“We are delighted to reach the milestone of first clinical CT Guided use for this revolutionary new ablation system.  The speed of ablation coupled with extreme ease of use offers clinicians a major advance on previous generation RFA technologies.  We see the system freeing valuable CT capacity while allowing clinicians to target larger and more numerous tumours.  The Acculis MTA System has been involved in an International multi-centre clinical audit since January 2008.  Initial data, presented at the recent international Liver Surgeons meeting in Buenos Aires, is pointing to lower recurrence and complication rates than documented for RFA.  These early indications point to 2.45GHz microwave as the next major breakthrough in volume ablation technologies.”  said Acculis CEO Stuart McIntyre

Acculis is a specialist medical device company developing microwave energy ablation systems for oncology applications. Acculis is part of the Microsulis group of companies. Microsulis and Acculis are based in Hampshire, England. For more information about the Acculis MTA System, visit www.acculis.com, or contact Caroline Hall at +44 2392 240011.